Jeffrey B. Mirviss - Dec 9, 2022 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role: EVP&Pres, Periph Intervent
Signature: /s/ Susan Thompson, Attorney-in-Fact
Stock symbol: BSX
Transactions as of: Dec 9, 2022
Transactions value $: -$1,506,349
Form type: 4
Date filed: 12/12/2022, 03:26 PM
Previous filing: Dec 5, 2022
Next filing: Dec 13, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BSX	Common Stock	Options Exercise	$387K	+29.6K	+26.67%	$13.08	141K	Dec 9, 2022	Direct	F1
transaction	BSX	Common Stock	Sale	-$1.89M	-41K	-29.19%	$46.15	99.6K	Dec 9, 2022	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BSX	Stock Option (Right to Buy)	Options Exercise	$0	-29.6K	-100%	$0.00^*	0	Dec 9, 2022	Common Stock	29.6K	$13.08	Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
F2	Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $45.97 to $46.26, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3	Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.